SCICLONE PHARMACEUTICALS INC
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: SCICLONE PHARMACEUTICALS INC, 10-Q, 2000-11-14
Next: PTEK HOLDINGS INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          17,542
<SECURITIES>                                         9
<RECEIVABLES>                                    9,423
<ALLOWANCES>                                         0
<INVENTORY>                                      1,706
<CURRENT-ASSETS>                                30,527
<PP&E>                                           1,314
<DEPRECIATION>                                   1,071
<TOTAL-ASSETS>                                  32,454
<CURRENT-LIABILITIES>                            5,505
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       143,571
<OTHER-SE>                                   (116,628)
<TOTAL-LIABILITY-AND-EQUITY>                    32,454
<SALES>                                         12,380
<TOTAL-REVENUES>                                12,380
<CGS>                                            2,497
<TOTAL-COSTS>                                    2,497
<OTHER-EXPENSES>                                12,250
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (1,600)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (1,600)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,600)
<EPS-BASIC>                                   (0.05)
<EPS-DILUTED>                                   (0.05)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission